factor VIII, human recombinant 1 UNT Injection

RxCUI
1719222
RxNorm name
factor VIII, human recombinant 1 UNT Injection
Display name
factor VIII, human recombinant 1 UNT Injection
Full name
factor VIII, human recombinant 1 UNT Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:23

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125574KovaltryAntihemophilic Factor (Recombinant), Full Length351(a)Rx2026-10-01
103375Bioclate (Armour), RecombinateAntihemophilic Factor (Recombinant)351(a)Rx2026-10-01
125063AdvateAntihemophilic Factor (Recombinant), Plasma/Albumin Free Method351(a)Rx2026-10-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
KovaltryANTIHEMOPHILIC FACTOR (RECOMBINANT)Bayer HealthCare LLC89ba5048-469c-4f08-a173-81b0c6f3004d2026-03-02Warnings, Adverse reactionsExact identifier
rxcui: 1719222
ADVATEANTIHEMOPHILIC FACTOR (RECOMBINANT)Takeda Pharmaceuticals America, Inc.80fa03d2-cd4c-4155-9b57-1396c4fa42da2025-04-03Warnings, Adverse reactionsExact identifier
rxcui: 1719222
RECOMBINATEANTIHEMOPHILIC FACTOR RECOMBINANTTakeda Pharmaceuticals America, Inc.d99348b1-edad-41de-aed9-903a6f9f279f2025-04-03Warnings, Adverse reactionsExact identifier
rxcui: 1719222

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 4 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
d99348b1-edad-41de-aed9-903a6f9f279fantihemophilic factor, human recombinant 1 UNT Injection [PSN] · antihemophilic factor, human recombinant 1 UNT Injection [SCD] · factor VIII, human recombinant 1 UNT Injection [SY]321RECOMBINATE ® [Antihemophilic Factor (Recombinant)]20250403
89ba5048-469c-4f08-a173-81b0c6f3004dantihemophilic factor, human recombinant 1 UNT Injection [PSN] · antihemophilic factor, human recombinant 1 UNT Injection [SCD] · factor VIII, human recombinant 1 UNT Injection [SY]318These highlights do not include all the information needed to use KOVALTRY safely and effectively. See full prescribing information for KOVALTRY. KOVALTRY [Antihemophilic Factor (Recombinant)] Lyophilized Powder for Solution for Intravenous Injection – Reconstitution with Vial Adapter Initial U.S. Approval: 201620260302
80fa03d2-cd4c-4155-9b57-1396c4fa42daantihemophilic factor, human recombinant 1 UNT Injection [PSN] · antihemophilic factor, human recombinant 1 UNT Injection [SCD] · factor VIII, human recombinant 1 UNT Injection [SY]313These highlights do not include all the information needed to use ADVATE ® safely and effectively. See full prescribing information for ADVATE. ADVATE [antihemophilic factor (recombinant)] lyophilized powder for reconstitution, for intravenous injection Initial U.S. Approval: 200320250403
d74e59ba-bfeb-4c48-9596-da44328561a9antihemophilic factor, human recombinant 1 UNT Injection [PSN] · antihemophilic factor, human recombinant 1 UNT Injection [SCD] · factor VIII, human recombinant 1 UNT Injection [SY]37RECOMBINATE [Antihemophilic Factor (Recombinant)]20100526